44 results
Page 2 of 3
DEFA14A
EX-99.1
p84e77rz v3
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
juldca gx93rrsfvhd
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.2
sd52ual
21 Dec 20
Regulation FD Disclosure
7:04am
424B5
38oha
8 Nov 19
Prospectus supplement for primary offering
5:03pm
424B5
box3vuhtyni5vtexif94
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
yrx2p
3 Jun 19
Other Events
4:02pm
8-K
EX-99.2
kz9ltvebf
3 Dec 18
Other Events
4:03pm
8-K
EX-99.1
ggnh4u
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
t0mb oya15
4 May 18
Results of Operations and Financial Condition
7:07am
424B4
fklzru
24 Apr 14
Prospectus supplement with pricing info
12:00am
DEF 14A
4pwqade68d3 z6apc
7 Apr 14
Definitive proxy
12:00am
10-K
gcs9teogskljb383
18 Mar 14
Annual report
12:00am